Announcement of the State Food and Drug Administration on the conversion of glucosamine sulfate effervescent tablets and glucosamine sulfate granules prescription drugs to over-the-counter drugs (No. 1 in 2020

According to the "Administrative Measures for the Classification of Prescription Drugs and Over-the-Counter Drugs (for Trial Implementation)" (State Drug Administration Order No.
10), after the State Drug Administration’s organization of demonstration and review, glucosamine sulfate effervescent tablets and glucosamine sulfate granules are two Medicines are converted from prescription drugs to over-the-counter drugs
.

The holders of the relevant drug marketing authorizations are requested to submit to the provincial drug regulatory authority for the record of the revised inserts in accordance with the "Administrative Measures for Drug Registration" and other relevant regulations before August 31, 2021, and promptly notify the relevant medical institutions and medical institutions of the revised contents of the inserts.
Units such as pharmaceutical business enterprises
.

The contents of the non-prescription drug inserts other than those specified in the template inserts shall be implemented in accordance with the original approval documents
.

Hereby announce
.

Attachment: 1.

2.
Templates for non-prescription drug instructions

State Food and Drug Administration

December 1, 2020

Announcement No.

Announcement No.